Inventor
DEAVER DANIEL R
US32 patents
⚠️ This page may combine multiple inventors who share the name “DEAVER DANIEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALKERMES PHARMA IRELAND LTD
24 patentsUS9682936B2Jun 20, 2017
Morphan and morphinan analogues, and methods of use
ALKERMES PHARMA IRELAND LTD14 citations92
US9656961B2May 23, 2017
Methods for treating depressive symptoms
ALKERMES PHARMA IRELAND LTD14 citations92
US9416137B2Aug 16, 2016
Morphan and morphinan analogues, and methods of use
ALKERMES PHARMA IRELAND LTD15 citations92
US9351976B2May 31, 2016
Pharmaceutical compositions comprising sorbitan esters
ALKERMES PHARMA IRELAND LTD22 citations92
US9193685B2Nov 24, 2015
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD17 citations92
US10752592B2Aug 25, 2020
Morphan and morphinan analogues, and methods of use
ALKERMES PHARMA IRELAND LTD8 citations84
US10736890B2Aug 11, 2020
Methods for treating depressive symptoms
ALKERMES PHARMA IRELAND LTD8 citations84
US10287250B2May 14, 2019
Morphan and morphinan analogues, and methods of use
ALKERMES PHARMA IRELAND LTD8 citations84
US10231963B2Mar 19, 2019
Methods for treating depressive symptoms
ALKERMES PHARMA IRELAND LTD8 citations84
US11351166B2Jun 7, 2022
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD3 citations83
US11241425B2Feb 8, 2022
Composition for treating mental illness
ALKERMES PHARMA IRELAND LTD3 citations83
US11185541B2Nov 30, 2021
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD3 citations83
US9861699B2Jan 9, 2018
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD8 citations83
US10226458B2Mar 12, 2019
Pharmaceutical compositions comprising sorbitan esters
ALKERMES PHARMA IRELAND LTD1 citations73
US11969469B2Apr 30, 2024
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD2 citations72
US11097006B2Aug 24, 2021
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD2 citations72
US10342877B2Jul 9, 2019
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD2 citations72
US12311027B2May 27, 2025
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD0 citations62
US12257249B2Mar 25, 2025
Methods for treating depressive symptoms
ALKERMES PHARMA IRELAND LTD0 citations62
US12194035B2Jan 14, 2025
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD0 citations62
US11793805B2Oct 24, 2023
Methods for treating antipsychotic-induced weight gain
ALKERMES PHARMA IRELAND LTD0 citations62
US11534436B2Dec 27, 2022
Methods for treating depressive symptoms
ALKERMES PHARMA IRELAND LTD0 citations62
US10806731B2Oct 20, 2020
Compositions of buprenorphine and μ antagonists
ALKERMES PHARMA IRELAND LTD0 citations52
US10639376B2May 5, 2020
Pharmaceutical compositions having improved storage stability
ALKERMES PHARMA IRELAND LTD0 citations51
PENN STATE RES FOUND
6 patentsUS5985320ANov 16, 1999
Materials and methods for enhancing cellular internalization
PENN STATE RES FOUND515 citations99
USRE42072EJan 25, 2011
Compositions and methods for enhancing receptor-mediated cellular internalization
PENN STATE RES FOUND51 citations98
USRE42012EDec 28, 2010
Compositions and methods for enhancing receptor-mediated cellular internalization
PENN STATE RES FOUND54 citations98
US6908623B2Jun 21, 2005
Compositions and methods for enhancing receptor-mediated cellular internalization
PENN STATE RES FOUND30 citations96
US6387390B1May 14, 2002
Compositions and methods for enhancing receptor-mediated cellular internalization
PENN STATE RES FOUND65 citations96
US6652873B2Nov 25, 2003
Compositions and methods for enhancing receptor-mediated cellular internalization
PENN STATE RES FOUND23 citations93